Betaferon 2 ml Lyophilised cake and solvent for solution for injection
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations.
Dosage (summary)
The recommended dose is 250 micrograms (0.5 mL) administered subcutaneously every other day.
Onset of Action / Duration
Initial effects may be observed within a few weeks, with maximum effects typically seen after several months of treatment.
Special Populations
- Elderly patients
- Patients with renal impairment
- Patients with hepatic impairment
Pregnancy & Breastfeeding
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised when administering to nursing mothers.
Key Drug Interactions
- Caution with other immunomodulatory therapies
- Potential interactions with live vaccines
Contraindications
- Hypersensitivity to recombinant interferon beta-1b or any excipients
- Severe depression or suicidal ideation
- Severe liver disease
Common side effects
- Flu-like symptoms (fever, chills, fatigue)
- Injection site reactions (redness, swelling, pain)
- Headache
- Nausea
- Depression
Counselling Points
- Instruct patients on proper injection technique and site rotation.
- Advise patients to report any signs of depression or mood changes.
- Encourage adherence to the dosing schedule for optimal efficacy.
Serious warnings
- Monitor for signs of liver dysfunction and hematologic abnormalities.
- Caution in patients with a history of seizures.
- May cause or exacerbate autoimmune disorders.
Important Disclaimer
The Betaferon 2 ml Lyophilised cake and solvent for solution for injection professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
